These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11637)

  • 1. Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).
    Bendtzen K
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):471-6. PubMed ID: 11637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):125-31. PubMed ID: 322257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte migration inhibitory factor (LIF). IV. 3',5'-cGMP protects LIF against inactivation by the esterase inhibitor phenylmethylsulfonyl fluoride.
    Bendtzen K
    Scand J Immunol; 1977; 6(12):1357-61. PubMed ID: 203999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte migration inhibitory factor (LIF). I. Effect of synthetic and naturally occurring esterase and protease inhibitors.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):126-31. PubMed ID: 322258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte migration inhibitory factor (LIF). II. Partial biochemical characterization of the substrate specificities for this lymphokine.
    Bendtzen K
    Scand J Immunol; 1977; 6(1-2):133-40. PubMed ID: 322260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.
    Bendtzen K
    Scand J Immunol; 1977; 6(10):1055-62. PubMed ID: 335493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leucocyte response to migration inhibitory activity from lymphocytes. Modification by aprotinin, Tranexamic acid and phenylmethyl sulfonylfluoride.
    Coeugniet E; Søeberg B; Bendixen G
    Acta Med Scand; 1978; 203(3):191-5. PubMed ID: 305717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity of the human lymphokine leucocyte migration-inhibitory factor (LIF): radioenzymic assay and inhibition by cGMP.
    Bendtzen K
    Scand J Immunol; 1979; 10(1):61-7. PubMed ID: 224450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chicken buffy coat leucocytes (BCL) as indicator cells for human leucocytes migration inhibitory factor (LIF).
    Bellina L; Salerno A
    J Immunol Methods; 1981; 43(3):277-81. PubMed ID: 7019345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of the serine protease inhibitor phenyl methyl sulfonyl fluoride on cytochemically detectable esterases in human leucocytes and platelets.
    Dufer J; Trentesaux C; Desplaces A
    Scand J Haematol; 1984 Jan; 32(1):25-32. PubMed ID: 6364322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human leukocyte migration inhibitory factor (LIF) by alpha-L-fucose.
    Bendtzen K
    Acta Allergol; 1975 Dec; 30(6):327-38. PubMed ID: 1106109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro assay of leukocyte migration inhibitory activity from human lymphocytes stimulated with concanavalin A.
    Bendtzen K; Andersen V; Bendixen G
    Acta Allergol; 1975 Jul; 30(2-3):133-49. PubMed ID: 1173991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the human lymphokine leukocyte migration inhibitory factor (LIF) by a sensitive radioenzymatic assay. Inhibitory effect of cGMP on the esterolytic activity of highly purified LIF.
    Bendtzen K
    J Clin Lab Immunol; 1979 Apr; 2(1):37-43. PubMed ID: 95804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human leucocyte migration inhibitory factor (LIF) on 3', 5'-cyclic AMP levels of peripheral blood leucocytes.
    Bendtzen K; Thode J; Madsen SN
    Acta Pathol Microbiol Scand C; 1977 Dec; 85C(6):473-9. PubMed ID: 204157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of leucocyte migration inhibitory factor (LIF) in infectious mononucleosis. Spontaneous release and lack of response to concanavalin A.
    Palit J; Bendtzen K; Andersen V
    Clin Exp Immunol; 1978 Jan; 31(1):66-71. PubMed ID: 639351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucocyte migration inhibitory activity (LMIA) on concanavalin A (Con-A) stimulated human lymphocytes. Comparison of leucocyte migration capillary technique (LMCT), leucocyte migration agarose technique (LMAT), and leucocyte migration fibrinolysis technique (LMFT).
    Coeugniet E; Bendixen G
    Acta Pathol Microbiol Scand C; 1976 Dec; 84C(6):485-8. PubMed ID: 793298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of the human lymphokine leukocyte migration inhibitory factor (LIF): role of cGMP as a specific inhibitor of the LIF esterase activity.
    Bendtzen K
    Adv Exp Med Biol; 1979; 114():485-90. PubMed ID: 223417
    [No Abstract]   [Full Text] [Related]  

  • 19. Human leucocyte migration inhibitory factor (LIF). V. Specific regulation of the lymphokine serine protease activity by 3',5'-cGMP and, possibly, 2',3'-cCMP.
    Bendtzen K
    Scand J Immunol; 1978; 8(1):53-61. PubMed ID: 212822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.